Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,219
Sort by:
2025 Molecular Diagnostics Market Shares in 61 Countries-Competitive Analysis of Leading and Emerging Market Players
US$ 4,500.00
This new report provides molecular diagnostics market shares for the following countries: Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand,...
January 2025
-
Global Metastatic Bone Disease Market Size Study, By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), By Origin of Metastasis (Breast, Lung, Thyroid, Kidney, Prostate, Others), By Treatment (Medication, Radiation Therapy, Surgical Intervention, Tumor Ablation Therapy), and Regional Forecasts 2022-2032
US$ 3,750.00
This substantial growth is attributed to the rising global incidence of cancer and advancements in therapeutic approaches that include radiopharmaceuticals, bisphosphonates, and other bone-targeting a...
January 2025
285 pages
Global Neuroendocrine Tumor Treatment Market Size Study, By Type (Meningiomas, Adrenal Cancer, Carcinoid Tumors, Paraganglioma), By Product (Somatostatin Analogs, Targeted Therapy, Others), By Site (Lung, Pancreas, Small Intestine, Stomach, Others), By End Use (Hospitals, Clinics, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The global neuroendocrine tumor treatment market was valued at USD 2.51 billion in 2023 and is projected to grow at a CAGR of 6.0% during the forecast period 2024-2032, reaching a market size of USD 4...
January 2025
285 pages
Hemoglobin A1c Testing Devices Market - 2025-2033
US$ 3,400.00
Hemoglobin A1c Testing Devices Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Hemoglobin A1c Testing Devices Market emerges as a key focus in DataM Intelligence lat...
January 2025
56 pages
Global Antimicrobial Susceptibility Testing Market Size Study, by Product (Manual Tests, Automated Instruments, Consumables & Media), by Technique (Disk Diffusion, Automated AST, Etest Method, Others), by Application (Drug Development, Susceptibility Testing, Others), by End-use (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The global Antimicrobial Susceptibility Testing (AST) market, valued at USD 3.42 billion in 2023, is projected to reach USD 5.35 billion by 2032, growing at a robust CAGR of 5.1% during the forecast p...
January 2025
285 pages
U.S. IVD and LDT for Autoimmune Diseases Market Size Study, By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), and Regional Forecasts 2022-2032
US$ 3,750.00
The U.S. IVD and LDT for Autoimmune Diseases Market is poised to achieve substantial growth in the forecast period, driven by the rising prevalence of autoimmune disorders and advancements in diagnost...
January 2025
285 pages
Global Kidney Cancer Drugs Market Size Study, by Type (Renal Cell Carcinoma (RCC), Transitional Cell Cancer, Wilms Tumor, Renal Sarcoma), by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), by Drug Class (Angiogenesis Inhibitors, Monoclonal Antibodies, mTOR Inhibitors, Cytokine Immunotherapy), by Route of Administration (Oral, Intravenous, Subcutaneous), by End Use (Hospital Pharmacies, Retail Pharmacies, Others), and Regional Forecasts 2022–2032
US$ 3,750.00
The global kidney cancer drugs market was valued at USD 6.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.9% over the forecast period from 2024 to 2032. This g...
January 2025
285 pages
